Andersen TI - Search Results

1

Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms.

Malkin D, Jolly KW, Barbier N, Look AT, Friend SH, Gebhardt MC, Andersen TI, Børresen AL, Li FP, Garber J, et al. Malkin D, et al. Among authors: andersen ti. N Engl J Med. 1992 May 14;326(20):1309-15. doi: 10.1056/NEJM199205143262002. N Engl J Med. 1992. PMID: 1565144 Free article.

2

Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.

Frebourg T, Kassel J, Lam KT, Gryka MA, Barbier N, Andersen TI, Børresen AL, Friend SH. Frebourg T, et al. Among authors: andersen ti. Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6413-7. doi: 10.1073/pnas.89.14.6413. Proc Natl Acad Sci U S A. 1992. PMID: 1631137 Free PMC article.

3

Screening for germ line TP53 mutations in breast cancer patients.

Børresen AL, Andersen TI, Garber J, Barbier-Piraux N, Thorlacius S, Eyfjörd J, Ottestad L, Smith-Sørensen B, Hovig E, Malkin D, et al. Børresen AL, et al. Among authors: andersen ti. Cancer Res. 1992 Jun 1;52(11):3234-6. Cancer Res. 1992. PMID: 1591732

4

Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations.

Børresen AL, Hovig E, Smith-Sørensen B, Malkin D, Lystad S, Andersen TI, Nesland JM, Isselbacher KJ, Friend SH. Børresen AL, et al. Among authors: andersen ti. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8405-9. doi: 10.1073/pnas.88.19.8405. Proc Natl Acad Sci U S A. 1991. PMID: 1924299 Free PMC article.

5

Alterations of the TP53 gene as a potential prognostic marker in breast carcinomas. Advantages of using constant denaturant gel electrophoresis in mutation detection.

Andersen TI, Børresen AL. Andersen TI, et al. Diagn Mol Pathol. 1995 Sep;4(3):203-11. doi: 10.1097/00019606-199509000-00008. Diagn Mol Pathol. 1995. PMID: 7493140

6

Prognostic significance of TP53 alterations in breast carcinoma.

Andersen TI, Holm R, Nesland JM, Heimdal KR, Ottestad L, Børresen AL. Andersen TI, et al. Br J Cancer. 1993 Sep;68(3):540-8. doi: 10.1038/bjc.1993.383. Br J Cancer. 1993. PMID: 8102535 Free PMC article.

7

Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas.

Andersen TI, Gaustad A, Ottestad L, Farrants GW, Nesland JM, Tveit KM, Børresen AL. Andersen TI, et al. Genes Chromosomes Cancer. 1992 Mar;4(2):113-21. doi: 10.1002/gcc.2870040203. Genes Chromosomes Cancer. 1992. PMID: 1373310

8

Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility.

Andersen TI, Heimdal KR, Skrede M, Tveit K, Berg K, Børresen AL. Andersen TI, et al. Hum Genet. 1994 Dec;94(6):665-70. doi: 10.1007/BF00206961. Hum Genet. 1994. PMID: 7989041

9

TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains.

Børresen AL, Andersen TI, Eyfjörd JE, Cornelis RS, Thorlacius S, Borg A, Johansson U, Theillet C, Scherneck S, Hartman S, et al. Børresen AL, et al. Among authors: andersen ti. Genes Chromosomes Cancer. 1995 Sep;14(1):71-5. doi: 10.1002/gcc.2870140113. Genes Chromosomes Cancer. 1995. PMID: 8527388

10

Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis.

Børresen AL, Ottestad L, Gaustad A, Andersen TI, Heikkilä R, Jahnsen T, Tveit KM, Nesland JM. Børresen AL, et al. Among authors: andersen ti. Br J Cancer. 1990 Oct;62(4):585-90. doi: 10.1038/bjc.1990.334. Br J Cancer. 1990. PMID: 1977466 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters